FRASCARELLI, CHIARA
FRASCARELLI, CHIARA
Dipartimento di Oncologia ed Emato-Oncologia
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact
2025 K. Venetis, C. Frascarelli, L.B. Bielo, G. Cursano, R. Adorisio, M. Ivanova, E. Mane, V. Peruzzo, A. Concardi, M. Negrelli, M. D'Ercole, F.M. Porta, Y. Zhan, A. Marra, D. Trapani, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, N. Fusco
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores
2024 M. Ivanova, C. Frascarelli, B. Cerbelli, M.G. Pignataro, A. Pernazza, K. Venetis, E. Sajjadi, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, P. Graziano, M. Martini, G. D'Amati, N. Fusco
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories
2024 F. Pepe, K. Venetis, G. Cursano, C. Frascarelli, P. Pisapia, D. Vacirca, C. Scimone, A. Rappa, G. Russo, E. Mane, F. Pagni, I. Castellano, G. Troncone, C.D. Angelis, G. Curigliano, E. Guerini-Rocco, U. Malapelle, N. Fusco
Concurrent presence of primary hemangioma and breast cancer metastasis within a lymph node: a case report inspired by the legacy of Professor Juan Rosai
2024 M. Ivanova, M. D'Ercole, F.M. Porta, B. Di Venosa, C. Frascarelli, C. Di Bella, F. Pagni, E. Guerini-Rocco, N. Fusco
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
2024 M. Ivanova, C. Pescia, D. Trapani, K. Venetis, C. Frascarelli, E. Mane, G. Cursano, E. Sajjadi, C. Scatena, B. Cerbelli, G. D'Amati, F.M. Porta, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
Deep learning algorithm on H&E whole slide images to characterize TP53 alterations frequency and spatial distribution in breast cancer
2024 C. Frascarelli, K. Venetis, A. Marra, E. Mane, M. Ivanova, G. Cursano, F.M. Porta, A. Concardi, A.G.M. Ceol, A. Farina, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, N. Fusco
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer
2024 E. Guerini-Rocco, K. Venetis, G. Cursano, E. Mane, C. Frascarelli, F. Pepe, M. Negrelli, E. Olmeda, D. Vacirca, A. Ranghiero, D. Trapani, C. Criscitiello, G. Curigliano, C. Rolfo, U. Malapelle, N. Fusco
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
2024 K. Venetis, C. Pescia, G. Cursano, C. Frascarelli, E. Mane, E. De Camilli, E. Munzone, S. Dellapasqua, C. Criscitiello, G. Curigliano, E. Guerini Rocco, N. Fusco
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
2023 M. Ivanova, F.M. Porta, F. Giugliano, C. Frascarelli, E. Sajjadi, K. Venetis, G. Cursano, G. Mazzarol, E. GUERINI ROCCO, G. Curigliano, C. Criscitiello, N. Fusco
Variants in ATP5F1B are associated with dominantly inherited dystonia
2023 A. Nasca, N.E. Mencacci, F. Invernizzi, M. Zech, I.J. Keller Sarmiento, A. Legati, C. Frascarelli, B.I. Bustos, L.M. Romito, D. Krainc, J. Winkelmann, M. Carecchio, N. Nardocci, G. Zorzi, H. Prokisch, S.J. Lubbe, B. Garavaglia, D. Ghezzi
Nanopore long-read next-generation sequencing for detection of mitochondrial DNA large-scale deletions
2023 C. Frascarelli, N. Zanetti, A. Nasca, R. Izzo, C. Lamperti, E. Lamantea, A. Legati, D. Ghezzi
Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing
2023 A. Ranghiero, C. Frascarelli, G. Cursano, C. Pescia, M. Ivanova, D. Vacirca, A. Rappa, S.V. Taormina, M. Barberis, N. Fusco, E.G. Rocco, K. Venetis
Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking
2023 C. Frascarelli, G. Bonizzi, C. Rosella Musico, E. Mane, C. Cassi, E. GUERINI ROCCO, A. Farina, A. Scarpa, R. Lawlor, L. Reggiani Bonetti, S. Caramaschi, A. Eccher, S. Marletta, N. Fusco
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
2023 N. Fusco, M. Ivanova, C. Frascarelli, C. Criscitiello, B. Cerbelli, M. Gemma Pignataro, A. Pernazza, E. Sajjadi, K. Venetis, G. Cursano, F. Pagni, C. Di Bella, M. Accardo, M. Amato, P. Amico, C. Bartoli, G. Bogina, L. Bortesi, R. Boldorini, S. Bruno, D. Cabibi, P. Caruana, E. Dainese, E. De Camilli, V. Dell’Anna, L. Duda, C. Emmanuele, G. Nicolò Fanelli, B. Fernandes, G. Ferrara, L. Gnetti, A. Gurrera, G. Leone, R. Lucci, C. Mancini, G. Marangi, M.G. Mastropasqua, L. Nibid, S. Orrù, M. Pastena, M. Peresi, L. Perracchio, A. Santoro, V. Vezzosi, C. Zambelli, V. Zuccalà, A. Rizzo, L. Costarelli, F. Pietribiasi, A. Santinelli, C. Scatena, G. Curigliano, E. Guerini-Rocco, M. Martini, P. Graziano, I. Castellano, G. D'Amati
PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients
2023 A. Di Donfrancesco, C. Berlingieri, M. Giacomello, C. Frascarelli, A.P. Magalhaes Rebelo, L.A. Bindoff, S. Reeval, P. Renbaum, F.M. Santorelli, G. Massaro, C. Viscomi, M. Zeviani, D. Ghezzi, E. Bottani, D. Brunetti
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods
2023 F.M. Porta, E. Sajjadi, K. Venetis, C. Frascarelli, G. Cursano, E. Guerini-Rocco, N. Fusco, M. Ivanova
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing
2023 K. Venetis, F. Pepe, C. Pescia, G. Cursano, C. Criscitiello, C. Frascarelli, E. Mane, G. Russo, B. Taurelli Salimbeni, G. Troncone, E. Guerini Rocco, G. Curigliano, N. Fusco, U. Malapelle